2Hofland LJ,van Hagen PM,Lamberts SW. Functional role of somatostatin receptors in neuroendocrine and immune cells.Ann Med, 1999,31(Suppl) :223-227
3Hofland LJ, Liu Q, Van Koetsveld PM, et al. Immunohistoc hemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors. J Clin Endocrinol Metab, 1999, 84:775-780
4Denzler B, Reubi JC. Expression of somatostatin receptor-s in peritumoral veins of human tumors. Cancer, 1999,85.. 188-198
5Pollak MN, Schally AV. Mechanism of antineoplastic action of somatostatin analogues. Proc Soc Exp Biol Med, 1998, 217:143-152
6Fruhwald, MC, D'Dorisio, MS, Pietsch, T, et al. High expression of somatostatin receptor subtype 2 in medulloblastoma:Implication for diagnosis and therapy. Pediatri Res, 1999,45:697-708
7Slooter GD, Mearadji A, Breeman WA. Somatostatin recep tor imaging, therapy and new strategies in patients with neuroendocrine tumours. Bri J Surg, 2001, 88:31-40
8Raderer M, Hamilton G, Kurtaran A, et al. Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results. Br J Cancer,1999,79:535-537
9Frioidevaux S, Hinterman E, Torok M, et al. Differential reg ulation of somatostatin receptor type 2 (sst2) expression in AR4 2J tumor cells implanted into mice during octreotide treatment. Cancer Res, 1999, 59:3652-3657
10Pailard F. Commentary: Somatostatin receptor gene transfer induces bystander effects. Human Gene Therapy, 1999, 10:857-859
